Mepartricin

Polyene macrolide antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is used as an antifungal agent, an antiprotozoal agent, and in the treatment of BENIGN PROSTATIC HYPERTROPHY.

Also Known As:

Networked: 63 relevant articles (6 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Badino, P: 2 articles (08/2006 - 08/2001)
2.	Odore, R: 2 articles (08/2006 - 08/2001)
3.	Re, G: 2 articles (08/2006 - 08/2001)
4.	Bruzzese, T: 2 articles (08/2001 - 01/2001)
5.	Andrałojć, Witold: 1 article (09/2021)
6.	Laskowski, Tomasz: 1 article (09/2021)
7.	Polit, Justyna: 1 article (09/2021)
8.	Szczeblewski, Paweł: 1 article (09/2021)
9.	Winnicki, Konrad: 1 article (09/2021)
10.	Żabka, Aneta: 1 article (09/2021)

Related Diseases

1.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/01/1998 - "Mepartricin proved to be an effective treatment of benign prostatic hyperplasia, determining an improvement in symptoms, quality of life, and peak urinary flow." 05/12/1986 - "[Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy]." 04/01/1988 - "[Evaluation of the objective efficacy of mepartricin in benign prostatic hypertrophy]." 01/01/1991 - "[The effects of mepartricin on the symptomatology of prostatic hypertrophy--double-blind controlled trial]." 04/01/2000 - "The effects of mepartricin (S-160) on spontaneous canine benign prostatic hyperplasia (BPH) were investigated by histological, histochemical and biochemical analysis. "
2.	Prostatitis 04/01/1988 - "[Mepartricin in the treatment of chronic prostatitis]." 04/01/1988 - "[Mepartricin in the symptomatic therapy of prostatitis]." 01/01/2004 - "To verify the efficacy of mepartricin versus placebo with regard to symptom improvement in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CPPS) and to verify a relation between hormonal levels and clinical improvement in these patients. " 01/01/2004 - "Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial." 03/01/2001 - "The aim of this paper is to compare the activity of mepartricin vs placebo in male pain pelvic syndrome secondary to chronic nonbacterial prostatitis/prostatodynia. "
3.	Pelvic Pain 01/01/2004 - "To verify the efficacy of mepartricin versus placebo with regard to symptom improvement in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CPPS) and to verify a relation between hormonal levels and clinical improvement in these patients. " 01/01/2004 - "Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial." 03/01/2001 - "The aim of this paper is to compare the activity of mepartricin vs placebo in male pain pelvic syndrome secondary to chronic nonbacterial prostatitis/prostatodynia. " 03/01/2001 - "[Mepartricin in the treatment of male pelvic pain syndrome secondary to chronic nonbacterial prostatitis/prostatodynia]." 03/01/2001 - "These data allow us to substain that mepartricin may be a useful and safe drug for the therapy of male pain pelvic syndrome secondary to chronic nonbacterial prostatitis/prostatodynia."
4.	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 07/01/1990 - "In order to more throughly study mepartricin pharmacodynamic characteristics, 2 groups of 15 patients with BPH and coexistent lipid metabolism disorders were studied in conformity with a sequential experimental design during which also systemic-acting (procetofen) and endoluminal-acting (cholestyramine) fat-lowering drugs were tried. "
5.	Vaginitis 07/01/1976 - "[Methyl-partricin and vaginitis. " 04/01/1973 - "[Methyl-partricin in the treatment of mycotic and protozoan vaginitis]." 11/01/1975 - "[Recent findings in the pharmacotherapy of vaginitis: methyl-partricin]." 09/01/1982 - "[Therapeutic possibilities of methyl-partricin in extemporaneous suspension in the local treatment of mycotic and protozoan vaginitis]." 07/01/1976 - "[Methyl-partricin tablets in the local treatment of vaginitis with double etiology (T. "

Related Drugs and Biologics

1.	Estrogens (Estrogen)
2.	Therapeutic Uses
3.	Macrolides
4.	Fenofibrate (CiL)
5.	Cholestyramine Resin (Questran)
6.	Anti-Bacterial Agents (Antibiotics)
7.	Adrenergic Agents (Adrenergic Drugs)
8.	Tablets
9.	Suspensions
10.	Mepartricin

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)